News - Sumatriptan
SAN DIEGO, June 6, 2011 /PRNewswire/ -- Thirty-six million Americans suffer from migraines, leading to more than $20 billion in medical expenses and costs related to lost productivity each year(1).
BEDFORD, Ohio, Sept. 7 /PRNewswire/ --- Bedford Laboratories(TM) is excited to announce they have further diversified their product offerings with the addition of pre-filled syringes.
BEDFORD, Ohio, Sept. 7 /PRNewswire/ --- Bedford Laboratories(TM) is excited to announce they have further diversified their product offerings with the addition of pre-filled syringes.
SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and rocuronium bromide injection.
